Side-by-side financials for EOLS and AZN. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | EOLS | AZN |
|---|---|---|
| Market cap | - | $286.27 B |
| US-listed rank | - | #48 |
| Revenue (latest FY) | $297.18M | - |
| Net income (latest FY) | -$51.64M | - |
| Net margin | -17.4% | - |
| SEC filings | 543 | 1,004 |
Full pages: Evolus, Inc. and AstraZeneca PLC, or browse the full rankings.